<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Genet</journal-id><journal-id journal-id-type="iso-abbrev">Front Genet</journal-id><journal-id journal-id-type="publisher-id">Front. Genet.</journal-id><journal-title-group><journal-title>Frontiers in Genetics</journal-title></journal-title-group><issn pub-type="epub">1664-8021</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6448008</article-id><article-id pub-id-type="doi">10.3389/fgene.2019.00229</article-id><article-categories><subj-group subj-group-type="heading"><subject>Genetics</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Bridging Basic and Clinical Research in Early Life Adversity, DNA Methylation, and Major Depressive Disorder</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Brown</surname><given-names>Amanda</given-names></name><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/601922/overview"/></contrib><contrib contrib-type="author"><name><surname>Fiori</surname><given-names>Laura M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Turecki</surname><given-names>Gustavo</given-names></name><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/48489/overview"/></contrib></contrib-group><aff><institution>McGill Group for Suicide Studies, Department of Psychiatry, McGill University</institution>, <addr-line>Montreal, QC</addr-line>, <country>Canada</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Tanja Maria Michel, University of Southern Denmark, Denmark</p></fn><fn fn-type="edited-by"><p>Reviewed by: Manish Kumar Jha, University of Texas Southwestern Medical Center, United States; Gopalkumar Rakesh, Duke University, United States</p></fn><corresp id="c001">*Correspondence: Gustavo Turecki, <email>gustavo.turecki@mcgill.ca</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Behavioral and Psychiatric Genetics, a section of the journal Frontiers in Genetics</p></fn></author-notes><pub-date pub-type="epub"><day>22</day><month>3</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>10</volume><elocation-id>229</elocation-id><history><date date-type="received"><day>17</day><month>8</month><year>2018</year></date><date date-type="accepted"><day>01</day><month>3</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 Brown, Fiori and Turecki.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Brown, Fiori and Turecki</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Early life adversity (ELA)- including childhood physical, emotional, and sexual abuse, as well as childhood neglect- is an important predictive factor for negative psychopathology, including Major Depressive Disorder (MDD). ELA can epigenetically regulate key emotional and behavioral systems in ways that can stably persist into adulthood and contribute to the development of MDD and other psychopathology. DNA methylation has been one of the most investigated forms of epigenetic regulation in ELA to MDD pathway. From these studies, genes and sites associated with ELA/MDD have been identified and should be further investigated in order to identify potential avenues for intervention.</p></abstract><kwd-group><kwd>epigenetics</kwd><kwd>major depressive disorder</kwd><kwd>early life adversity</kwd><kwd>DNA methylation</kwd><kwd>biomarkers</kwd><kwd>antidepressant therapies</kwd></kwd-group><counts><fig-count count="0"/><table-count count="1"/><equation-count count="0"/><ref-count count="90"/><page-count count="10"/><word-count count="0"/></counts></article-meta></front><body><sec><title>Introduction</title><p>Early life adversity (ELA)- which includes forms of child maltreatment such as physical abuse, sexual abuse, psychological and emotional abuse, and childhood neglect- remains a major public health and welfare issue in high income countries (<xref rid="B36" ref-type="bibr">Krugers et al., 2017</xref>). It is defined as any act that is either actively conducted, or neglected to be conducted, by a parent or caregiver that either harms or has potential to harm a child, regardless of intent. These acts include physical abuse such as hitting, punching, beating, strangling, and shaking, sexual abuse such as penetration, sexual contact, and exposure to sexual activity, emotional and psychological abuse such as terrorizing, intimidating, and belittling, and forms of neglect such as failure to provide clothing, food, shelter, or neglect in seeking medical care for a child (<xref rid="B39" ref-type="bibr">Leeb et al., 2008</xref>). Overall, the various forms of ELA are estimated to affect approximately 10&#x02013;15% of children (typically categorized as individuals under the age of 18). Specifically, between 4 and 16% of children experience physical abuse, and approximately 15% of children are subjected to sexual abuse annually (<xref rid="B17" ref-type="bibr">Fergusson et al., 2000</xref>; <xref rid="B88" ref-type="bibr">Woodman et al., 2008</xref>; <xref rid="B23" ref-type="bibr">Gilbert et al., 2009</xref>).</p><p>In the United States, approximately 80% of substantiated ELA cases are found to be perpetuated by either one or both parents, with 77% of physical abuse, 26% of sexual abuse, 81% of emotional/psychological abuse, and 87% of neglect cases being perpetrated by a parent (<xref rid="B82" ref-type="bibr">US Department of Health and Human Services, 2008</xref>; <xref rid="B31" ref-type="bibr">Jonson-Reid et al., 2012</xref>; <xref rid="B56" ref-type="bibr">Nemeroff, 2016</xref>). Additionally, 29% of sexual abuse cases are perpetrated by a non-parent relative (<xref rid="B17" ref-type="bibr">Fergusson et al., 2000</xref>). It is worth noting that these estimates reflect only officially reported and substantiated cases, and that the actual burden of ELA likely exceeds these estimates.</p><p>This substantial phenomenon of ELA is of particular importance as a public health issue considering that repeated exposure to ELA, as well as exposure to multiple types of ELA, has the potential to inflict severe and lasting physical and psychological consequences that represent serious public healthcare and legal costs, as well as increased risk of mortality (<xref rid="B23" ref-type="bibr">Gilbert et al., 2009</xref>). ELA has been shown to contribute significantly to the risk of criminal behavior, childhood/adolescent behavioral problems, general physical heath, obesity, promiscuity, prostitution and sex trading, substance use, attempted suicide, and various psychopathologies such as post-traumatic stress disorder (PTSD), and Major Depressive Disorder (MDD), bipolar disorder, and conduct disorder (<xref rid="B76" ref-type="bibr">Thomas et al., 2008</xref>; <xref rid="B23" ref-type="bibr">Gilbert et al., 2009</xref>; <xref rid="B86" ref-type="bibr">Weder et al., 2014</xref>; <xref rid="B56" ref-type="bibr">Nemeroff, 2016</xref>; <xref rid="B36" ref-type="bibr">Krugers et al., 2017</xref>).</p><p>The role of ELA in the development of MDD is of particular interest with regard to public health and welfare, as MDD is the leading cause of global disability, affecting over 300 million people worldwide (<xref rid="B89" ref-type="bibr">World Health Organization [WHO], 2017</xref>). It is characterized by persistent depressed mood and loss of interest and pleasure, and may also include symptoms such as weight loss or gain, insomnia or hypersomnia, fatigue, loss of motivation or concentration, recurring thoughts of death, and suicidal ideation (<xref rid="B90" ref-type="bibr">Zajecka et al., 2013</xref>).</p><p>It is believed that exposure to repeated ELA may increase risk for MDD by cumulating in a hostile and unstable early environment that may trigger adaptive responses in the brain in crucial response systems (such as stress and emotional regulation). There is evidence that these regulatory changes can stably and radically impact aspects of personality development and cognitive functioning in ways that can increase the risk for MDD and associated psychopathologies (<xref rid="B68" ref-type="bibr">Saavedra et al., 2016</xref>). The etiology underlying the pathophysiology of MDD is a complex and often varied interplay between genetic, epigenetic, environmental, clinical, and social factors. Research suggests that one of these factors-ELA-can trigger epigenetic alterations (through events such as DNA methylation) in neural systems and genes associated with increased stress response [such as the in the hypothalamic pituitary adrenal axis (HPA)] as a survival mechanism. The persistence of these epigenetic changes often become maladaptive as the early life environment changes, but the altered function of the stress systems does not. While it is not fully understood how these alterations contribute specifically to MDD symptomology, DNA methylation events in these systems in individuals who have experienced ELA have been associated with MDD (<xref rid="B68" ref-type="bibr">Saavedra et al., 2016</xref>; <xref rid="B61" ref-type="bibr">Pishva et al., 2017</xref>).</p><p>It is worth noting that ELA itself is a complex set of phenomena that increases the complexity of MDD pathophysiology, and includes different severities and consequences. There is evidence of a dose-response relationship between ELA and psychopathologies such as MDD, wherein a higher severity of childhood adversity has been linked to increased incidence of psychopathology, higher comorbidity among psychiatric diagnoses, and more severe symptoms within diagnoses (<xref rid="B15" ref-type="bibr">Edwards et al., 2003</xref>; <xref rid="B6" ref-type="bibr">Chapman et al., 2004</xref>; <xref rid="B27" ref-type="bibr">Heim and Binder, 2012</xref>).</p><p>With respect to MDD specifically, ELA has been shown to correspond to a more severe course of depression, particularly in terms of increased chronicity, resistance to psychopharmacology and psychotherapy, and greater presentation of atypical symptoms (such as hypersomnia, increased appetite, and increased sensitivity to rejection) (<xref rid="B87" ref-type="bibr">Withers et al., 2013</xref>).</p><p>There is evidence that certain factors, such as microstructural differences in white matter, as measured by fractional anisotropy, and increased neural fiber connectivity, may be protective against the development of MDD in individuals who experienced ELA. Fractional anisotropy measures the anisotropic movement of water molecules (thought to be important in extrasynaptic communication) associated with fiber bundles (<xref rid="B51" ref-type="bibr">Morgan et al., 2013</xref>). One study found that unaffected first degree relatives of individuals with MDD, who also experienced ELA, had significantly increase fractional anisotropy in the right frontal and orbitofrontal lobes, corpus callosum, inferior fronto-occipital fasciculus (IFO), left superior longitudinal fasciculus (SLF) and right fornix (<xref rid="B18" ref-type="bibr">Frodl et al., 2012</xref>).</p><p>However, resilience is a complex topic in ELA and MDD research, and personal coping mechanisms, behavioral factors, and the presence of positive interpersonal influences concurrent with the ELA were not examined in this study. Epigenetic regulation related to the growth factor brain-derived neurotrophic factor (BDNF) may also play a role in conferring resilience to MDD in these circumstances, and deserves further investigation (<xref rid="B35" ref-type="bibr">Krishnan et al., 2007</xref>). Due to all of these intersecting factors, resilience from MDD in the presence of ELA is therefore difficult to study and adequately quantify. Regardless, while certain biological and environmental factors may act as protective factors against MDD development in individuals who have experienced ELA in ways that are not yet fully understood, it remains true that ELA is one of the greatest risk factors for the development of MDD (<xref rid="B68" ref-type="bibr">Saavedra et al., 2016</xref>).</p><p>Considering the prominent role that severe ELA plays in the development of MDD, and the overall prevalence of MDD, these figures indicate that ELA imposes a substantial social, economic, and public health cost upon society. Due to this, research identifying the mechanisms of action in the ELA to MDD pathway could prove to be a great asset in the development of clinical treatments of MDD. One mechanism by which ELA has been shown to influence emotional and stress regulation systems is epigenetic regulation, such as DNA methylation (<xref rid="B4" ref-type="bibr">Cecil et al., 2016</xref>). Although other forms of ELA have been examined with respect to the ELA to MDD pathway, DNA methylation remains one of the most predominately studied, and will serve as the focus of this review. Here, we will first explore how DNA methylation has been implicated in ELA and MDD, and then examine how DNA methylation also has the potential to impact clinical research into MDD diagnosis and treatment.</p></sec><sec><title>DNA Methylation in ELA/MDD</title><p>Epigenetic regulation describes any regulatory event which causes alterations in gene expression without changes to the original DNA sequence. Various forms of epigenetic regulation have been extensively studied as causal factors in the depression endophenotype in individuals who have experienced ELA, including DNA methylation, histone modifications, and microRNA.</p><p>DNA methylation is one of the most well-investigated forms of epigenetic regulation and has been studied as a causal factor in the development of MDD in both candidate gene and genome wide studies (<xref rid="B42" ref-type="bibr">Lutz et al., 2015</xref>). During DNA methylation, the DNA is covalently modified via addition of a methyl group to a cytosine nucleotide. This phenomenon is particularly common in cytosine-guanine dinucleotides (CpGs) (<xref rid="B30" ref-type="bibr">Jin et al., 2011</xref>). The methylation status of the nucleotide is read by methyl CpG-binding domain (MBD) proteins- such as MeCP2 and MBD1-4- which interact with histone deactylases and DNA-methyltransferases that induce chromatin condensation (<xref rid="B8" ref-type="bibr">Chen et al., 2003</xref>; <xref rid="B5" ref-type="bibr">Chahrour et al., 2008</xref>; <xref rid="B25" ref-type="bibr">Guy et al., 2011</xref>). When methylation is found in promoter regions, it can interfere with transcription factor binding and lead to gene silencing. Conversely, site specific dissociation of the MBDs &#x02013; specifically MeCP2- have been associated with demethylation, and have been implicated to play a major role in maintaining DNA methylation status (<xref rid="B46" ref-type="bibr">Martinowich et al., 2003</xref>).</p><p>During prenatal development, DNA methylation patterns are crucial to the process of cell differentiation. However, changes in DNA methylation occur beyond this period, as a mechanism that helps the genome adapt to external signals in the environment. This form of DNA methylation allows the genome to adjust its function through diverse -yet stable- changes. This is one possible mechanism by which environmental stressors such as ELA may trigger epigenetic changes that could ultimately contribute to psychopathology such as MDD (<xref rid="B78" ref-type="bibr">Turecki, 2014</xref>).</p></sec><sec><title>Genome-Wide and Multiple Loci Studies</title><sec><title>Human Post Mortem Brain Tissue Studies</title><p>In addition to approaches based on the investigation of candidate genes, the role of DNA Methylation in ELA/MDD has also been examined using larger-scale, genome-wide studies. One of the earliest studies examined hippocampal tissue from French Canadian men with a history of severe childhood abuse (who also died by suicide) using meDIP, an antibody targeting methylated cytosines, coupled with an tiled array containing gene promoters. Differential DNA methylation indicated that 248 sites were hypermethylated and 114 were hypomethylated (<xref rid="B38" ref-type="bibr">Labont&#x000e9; et al., 2012</xref>). Significant differences involved genes implicated in cellular or neural plasticity, and some of these findings included histone cluster 2 H2ab (<italic>HIST2H2AB</italic>), nuclear receptor subfamily 1, group D, member 1 (<italic>NR1D1</italic>); and amyotrophic lateral sclerosis 2 (<italic>ALS2</italic>). Specifically, <italic>in vitro</italic> analysis of <italic>ALS2</italic> methylation levels indicated functional effects on gene expression- supporting the hypothesis that ELA contributes to cell-type specific reprogramming of the epigenome in ways that may influence emotional and behavioral dysregulation (<xref rid="B42" ref-type="bibr">Lutz et al., 2015</xref>).</p><p>In another region of the brain that is hypothesized to be implicated in ELA/MDD- the anterior cingulate cortex (ACC) &#x02013; genome-wide DNA methylation was assessed using reduced representation bisulfite sequencing (RRBS) in human post mortem brain tissue of depressed suicides who experienced ELA (<xref rid="T1" ref-type="table">Table 1</xref>) (<xref rid="B44" ref-type="bibr">Lutz et al., 2017b</xref>). In this study, the most significantly differentially methylated genes were those related to myelin and oligodendrocytes. Specifically, the three most differentially methylated genes were <italic>LINGO3</italic> (which codes for LINGO proteins that are implicated in myelination), <italic>POU3F1</italic> (a transcription factor that controls myelination), and <italic>ITGB1</italic> (an integrin that mediates oligodendrocyte and axonal interactions). These findings suggested that ELA may lead to myelin alterations, a conclusion also supported by both transcriptomic and morphological changes observed in this study using other techniques (<xref rid="T1" ref-type="table">Table 1</xref>) (<xref rid="B44" ref-type="bibr">Lutz et al., 2017b</xref>), and consistent with pre-clinical studies indicating that a critical period in the early social environment regulates myelination that in turn is essential for normal cognitive function (<xref rid="B45" ref-type="bibr">Makinodan et al., 2012</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Summary of studies investigating clinical applications of ELA and MDD research involving- or related to &#x02013; DNA methylation in ELA and MDD.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Reference</th><th valign="top" align="left" rowspan="1" colspan="1">Sample Size<sup>&#x02217;</sup></th><th valign="top" align="left" rowspan="1" colspan="1">Adversity Group</th><th valign="top" align="left" rowspan="1" colspan="1">Sample</th><th valign="top" align="left" rowspan="1" colspan="1">Purpose</th><th valign="top" align="left" rowspan="1" colspan="1">Methodology</th><th valign="top" align="left" rowspan="1" colspan="1">Data</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B20" ref-type="bibr">Fuchikami et al., 2011</xref></td><td valign="top" align="left" rowspan="1" colspan="1">38 (20+18)</td><td valign="top" align="left" rowspan="1" colspan="1">MDD</td><td valign="top" align="left" rowspan="1" colspan="1">Blood</td><td valign="top" align="left" rowspan="1" colspan="1">Diagnostic biomarker</td><td valign="top" align="left" rowspan="1" colspan="1">Bisulphite sequencing</td><td valign="top" align="left" rowspan="1" colspan="1">DNA methylation in BDNF</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B41" ref-type="bibr">Lopez et al., 2013</xref></td><td valign="top" align="left" rowspan="1" colspan="1">25</td><td valign="top" align="left" rowspan="1" colspan="1">Treatment na&#x000ef;ve MDD</td><td valign="top" align="left" rowspan="1" colspan="1">Blood</td><td valign="top" align="left" rowspan="1" colspan="1">Antidepressant efficacy biomarker</td><td valign="top" align="left" rowspan="1" colspan="1">qRT-PCR</td><td valign="top" align="left" rowspan="1" colspan="1">BDNF concentration</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B60" ref-type="bibr">Perroud et al., 2013</xref></td><td valign="top" align="left" rowspan="1" colspan="1">167 (52+115)</td><td valign="top" align="left" rowspan="1" colspan="1">BPD and ELA</td><td valign="top" align="left" rowspan="1" colspan="1">Blood</td><td valign="top" align="left" rowspan="1" colspan="1">Psychotherpay efficacy biomarker</td><td valign="top" align="left" rowspan="1" colspan="1">High-resolution melt assay</td><td valign="top" align="left" rowspan="1" colspan="1">DNA methylation in BDNF</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B53" ref-type="bibr">Mundorf et al., 2018</xref></td><td valign="top" align="left" rowspan="1" colspan="1">60</td><td valign="top" align="left" rowspan="1" colspan="1">MDD and ELA</td><td valign="top" align="left" rowspan="1" colspan="1">Buccal cells</td><td valign="top" align="left" rowspan="1" colspan="1">Diagnostic biomarker</td><td valign="top" align="left" rowspan="1" colspan="1">Bisulfite sequencing (with EpiTect Kit)</td><td valign="top" align="left" rowspan="1" colspan="1">DNA methylation in MORC1</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B9" ref-type="bibr">Covington et al., 2009</xref></td><td valign="top" align="left" rowspan="1" colspan="1">Mouse model</td><td valign="top" align="left" rowspan="1" colspan="1">Chronic social defeat</td><td valign="top" align="left" rowspan="1" colspan="1">Mouse NaC tissue</td><td valign="top" align="left" rowspan="1" colspan="1">Antidepressant efficacy biomarker</td><td valign="top" align="left" rowspan="1" colspan="1">Gene expression arrays</td><td valign="top" align="left" rowspan="1" colspan="1">Expression levels of 12 genes in the NAc</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B48" ref-type="bibr">Melas et al., 2012</xref></td><td valign="top" align="left" rowspan="1" colspan="1">Mouse model</td><td valign="top" align="left" rowspan="1" colspan="1">Flinders sensitive line (FSL) genetic rodent model of depression</td><td valign="top" align="left" rowspan="1" colspan="1">Mouse prefrontal cortex tissue</td><td valign="top" align="left" rowspan="1" colspan="1">Antidepressant efficacy biomarker</td><td valign="top" align="left" rowspan="1" colspan="1">Pyrosequencing</td><td valign="top" align="left" rowspan="1" colspan="1">DNA methylation in P11</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B44" ref-type="bibr">Lutz et al., 2017b</xref></td><td valign="top" align="left" rowspan="1" colspan="1">78 (52+26)</td><td valign="top" align="left" rowspan="1" colspan="1">MDD/suicide +ELA and MDD/suicide without ELA</td><td valign="top" align="left" rowspan="1" colspan="1">Human post mortem ACC Tissue</td><td valign="top" align="left" rowspan="1" colspan="1">Quantifying myelination alterations in MDD</td><td valign="top" align="left" rowspan="1" colspan="1">bisulfite sequencing/RNA sequencing/stereology and coherent anti-Stokes Raman scattering microscopy.</td><td valign="top" align="left" rowspan="1" colspan="1">Methylation and expressionlevels of myelin related genes, and imaging of oligodendrocytes and myelinated axons</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B32" ref-type="bibr">Kaufman et al., 2018</xref></td><td valign="top" align="left" rowspan="1" colspan="1">157</td><td valign="top" align="left" rowspan="1" colspan="1">Children who experienced ELA</td><td valign="top" align="left" rowspan="1" colspan="1">Saliva and neuroimaging data</td><td valign="top" align="left" rowspan="1" colspan="1">Predicting depression in children who experienced ELA</td><td valign="top" align="left" rowspan="1" colspan="1">Illumina 450?K beadchip/fMRI</td><td valign="top" align="left" rowspan="1" colspan="1">DNA methylation in OTX2 and functional connectivity between the ventromedial prefrontal cortex and structures of the medial frontal cortex</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B69" ref-type="bibr">Sacchet and Gotlib, 2017</xref></td><td valign="top" align="left" rowspan="1" colspan="1">80 (40 +40)</td><td valign="top" align="left" rowspan="1" colspan="1">MDD</td><td valign="top" align="left" rowspan="1" colspan="1">Neuroimaging data</td><td valign="top" align="left" rowspan="1" colspan="1">Quantifying myleination alterations in MDD</td><td valign="top" align="left" rowspan="1" colspan="1">qMRI</td><td valign="top" align="left" rowspan="1" colspan="1">Whole brain, Nac, lateral PFC myelin levels</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><attrib><italic><sup>&#x02217;</sup>sample size: total (adversity group+ control cohort)</italic>.</attrib></table-wrap-foot></table-wrap></sec><sec><title>Peripheral Tissue Studies</title><p>Other studies evaluated DNA methylation changes associated with ELA, using peripheral samples. A study investigating methylation in the promoter region of over 20 000 genes, including 489 coding for miRNAs, in the blood DNA of males in the 1958 British Birth Cohort found 997 differentially methylated gene promoters associated with ELA (311 hypermethylated and 686 hypomethylated), which were enriched for genes involved in processes such as transcriptional regulation and development. Additionally, they observed ELA associated methylation in thirty-one miRNA genes, six of which showed hypermethylation consistent with hypomethylation observed in their downstream gene targets (<xref rid="B73" ref-type="bibr">Suderman et al., 2015</xref>). Another genome wide study by <xref rid="B86" ref-type="bibr">Weder et al. (2014)</xref> used the Illumina 450K BeadChip array to determine potential sites of differential methylation that could predict depression in saliva samples collected from maltreated children compared to non-traumatized. Three genes emerged as predictors of depression in combination with ELA: DNA-Binding Protein Inhibitor ID&#x02013;3 (<italic>ID3</italic>); and Tubulin Polymerization Promoting Protein (<italic>TPPP</italic>) (<xref rid="B86" ref-type="bibr">Weder et al., 2014</xref>); and the neurotransmitter gene glutamate receptor, ionotropic <italic>N</italic>-methyl-<sc>D</sc>-aspartate 1 (GRIN1) (<xref rid="B86" ref-type="bibr">Weder et al., 2014</xref>).</p><p>More recently, the Illumina 450K BeadChip array was used by the same group in another study of ELA and MDD that sought to predict differential DNA methylation in maltreated children. In this study (<xref rid="B32" ref-type="bibr">Kaufman et al., 2018</xref>), methylation of the Orthodenticle homeobox 2 (<italic>OTX2</italic>) gene significantly predicted depression in saliva samples of maltreated children compared to controls (<xref rid="T1" ref-type="table">Table 1</xref>) (<xref rid="B32" ref-type="bibr">Kaufman et al., 2018</xref>).</p></sec><sec><title>Neuroimaging</title><p>Imaging data revealed that methylation of <italic>OTX2</italic> is associated with increased functional connectivity between the ventromedial prefrontal cortex and structures of the medial frontal cortex that have been implicated in MDD- such as the paracingulate gyrus, frontal pole, and subcallosal gyrus (<xref rid="T1" ref-type="table">Table 1</xref>) (<xref rid="B32" ref-type="bibr">Kaufman et al., 2018</xref>).</p></sec></sec><sec><title>Candidate Genes</title><sec><title>HPA Axis</title><p>Numerous candidate gene studies have also investigated the relationship between ELA, depressive symptoms, and DNA methylation. The majority of these studies have been performed in peripheral samples such as blood and saliva. However, studies utilizing brain and CNS related tissues and systems have also been widely performed in both animal models and human post mortem tissue studies. One biological system in particular, the hypothalamic-pituitary-adrenal (HPA) axis has been the focus of many of these studies.</p><p>The HPA axis is a primary stress response system in mammals that has been extensively studied for its role in various psychopathologies including MDD, bipolar disorder, hypersexual disorder, and behaviors like habitual smoking (<xref rid="B64" ref-type="bibr">Rohleder and Kirschbaum, 2006</xref>; <xref rid="B7" ref-type="bibr">Chatzittofis et al., 2016</xref>; <xref rid="B55" ref-type="bibr">Murri et al., 2016</xref>). The HPA response begins in neurons in the paraventricular nucleus (PVN) of the hypothalamus, where the neurohormones CRF and arginine vasopressin (AVP) are released into blood vessels between the hypothalamus and pituitary gland. The pituitary gland is then stimulated to secrete adrenocorticotropic hormone (ACTH) into the circulation to induce the synthesis and secretion of glucocorticoids like cortisol from the adrenal glands (<xref rid="B57" ref-type="bibr">Pariante and Lightman, 2008</xref>; <xref rid="B59" ref-type="bibr">Perroud et al., 2011</xref>; <xref rid="B33" ref-type="bibr">Keller et al., 2016</xref>).</p><p>Studies have demonstrated that ELA can foster HPA axis dysfunction in ways that increase susceptibility to depression. Specifically, this dysfunction may result from disturbances to the negative feedback system of the HPA axis, which is partially controlled by the expression of the glucocorticoid receptor (<italic>GR/NR3C1</italic>) in the hippocampus, expression of the <italic>CRF</italic> gene, or changes in <italic>FKBP5</italic> expression- a gene responsible for stabilizing the conformation of the GR (<xref rid="B57" ref-type="bibr">Pariante and Lightman, 2008</xref>; <xref rid="B33" ref-type="bibr">Keller et al., 2016</xref>).</p></sec><sec><title>Animal Models</title><p>Animal models of maternal care have provided a substantial contribution to the understanding of the relationship between the early environment and functioning of the HPA axis. Rats who receive decreased maternal attention in the form of low licking-grooming (LG) behavior in the first week of life have been found to show increased HPA stress responses and hypothalamic corticotrophin releasing factor (CRF) expression, and decreased GR expression and glucocorticoid feedback sensitivity compared to high LG rats. This is due in large part to differential methylation of the <italic>GR/NR3C1</italic> gene which is downregulated in low LG rats, with increased DNA methylation being observed in the promoter region (exon 17) of <italic>NR3C1</italic> in the hippocampus, which persists into adulthood (<xref rid="B84" ref-type="bibr">Weaver et al., 2007</xref>, <xref rid="B85" ref-type="bibr">2014</xref>).</p><p>In addition to <italic>NR3C1</italic>, hypothalamic corticotrophin releasing factor (CRF), also plays a key role in this feedback system and exerts control over the HPA axis and other stress responses in the brain. Mice subjected to chronic social defeat display decreased DNA methylation in the <italic>CRF</italic> gene, leading to sustained upregulation of <italic>CRF</italic> in neurons of the paraventricular nucleus (PVN) in the hypothalamus (<xref rid="B16" ref-type="bibr">Elliott et al., 2010</xref>). This ELA model leads to stress-induced phosphorylation of MeCP2, which results in MeCP2 being dissociated from the inhibitory complex of methylated CpG sites in the <italic>CRF</italic> promotor region, resulting in increased transcription. This mechanism of <italic>CRF</italic> upregulation is supported by the observation that mice with MeCP2 knockouts in the PVN present with abnormal physiological stress responses (<xref rid="B22" ref-type="bibr">Fyffe et al., 2008</xref>). Conversely, a rat model of chronic mild stress actually demonstrated increased DNA methylation of the <italic>CRF</italic> promoter in the PVN, indicating that sex-specific and/or dose-dependent effects may play a role in altered HPA axis activity (<xref rid="B71" ref-type="bibr">Sterrenburg et al., 2011</xref>).</p></sec><sec><title>Human Post Mortem Brain Tissue Studies</title><p>Human post mortem brain tissue studies have also demonstrated ELA-associated epigenetic changes in the HPA axis, as hippocampal tissue obtained from individuals who died by suicide and experienced ELA (particularly severe childhood abuse) displayed an increase in <italic>NR3C1</italic> methylation, and decreased <italic>NR3C1</italic> expression (<xref rid="B47" ref-type="bibr">McGowan et al., 2009</xref>; <xref rid="B74" ref-type="bibr">Suderman et al., 2012</xref>).</p><p>Finally, in the neurons of the hypothalamic paraventricular nucleus, increased arginine vasopressin (AVP) release accompanied by HPA axis hypersensitivity has also been linked to hypomethylation in reduced maternal care animals, in a similar mechanism to <italic>CRF</italic> hypomethylation (<xref rid="B54" ref-type="bibr">Murgatroyd et al., 2009</xref>).</p></sec><sec><title>Peripheral Tissue Studies</title><p>The GR regulating gene, <italic>FKBP5</italic>, has also been the subject of several studies investigating differential methylation in peripheral tissue. Certain polymorphisms of <italic>FKBP5</italic> (rs1360780, rs9296158, rs3800373, and rs9470080) interact with ELA to predict MDD and suicide attempts (<xref rid="B67" ref-type="bibr">Roy et al., 2010</xref>; <xref rid="B2" ref-type="bibr">Appel et al., 2011</xref>). One study by <xref rid="B34" ref-type="bibr">Klengel et al. (2012)</xref> examined <italic>FKBP5</italic> methylation levels in the blood of individuals with a history of ELA and found hypomethylation in intron seven. Another study collected saliva samples from children who had experienced ELA, and assessed them for DNA methylation levels at two CpG sites in intron seven of <italic>FKBP5</italic> (<xref rid="B79" ref-type="bibr">Tyrka et al., 2015</xref>). Once again, hypomethylation was found at both sites in intron seven. It was hypothesized that increased cortisol release following ELA in <italic>FKBP5</italic> risk allele carriers would signal differential methylation in <italic>FKBP5</italic> and disrupt the feedback loop responsible for <italic>FKBP5</italic> and GR activity, leading to stress response dysregulation and increased susceptibility to MDD (<xref rid="B79" ref-type="bibr">Tyrka et al., 2015</xref>).</p></sec></sec><sec><title>Neurotransmitters</title><p>DNA methylation in neurotransmitter genes has also been explored in CNS and peripheral human samples, as well as animal studies, with respect to the ELA to MDD pathway. In addition to the previous discussed Weder et al. study that implicated the neurotransmitter gene glutamate receptor, ionotropic <italic>N</italic>-methyl-<sc>D</sc>-aspartate 1 (GRIN1) in ELA/MDD, one gene, <italic>5-HT2A</italic>, has been explored in the prefrontal cortex (PFC) for its potential contribution to ELA related MDD and suicide (<xref rid="B13" ref-type="bibr">Du et al., 2000</xref>, <xref rid="B14" ref-type="bibr">2001</xref>; <xref rid="B11" ref-type="bibr">De Luca et al., 2007</xref>, <xref rid="B12" ref-type="bibr">2009</xref>). One particular <italic>5-HT2A</italic> polymorphism, the C allele (C102T), has been associated with depression and suicide, and has been found to be more abundant in the PFC of suicides. Although non-significant hypomethylation differences were found in the C allele in suicides, hypermethylation was reported in suicide ideators, indicating potential differential methylation patterns between these two groups (<xref rid="B12" ref-type="bibr">De Luca et al., 2009</xref>).</p><p>In the anterior insula, downregulation of the kappa opioid receptor (<italic>Kappa</italic>) and decreased DNA methylation in the second intron of the <italic>Kappa</italic> gene has been found in depressed suicides who experienced ELA. This intron serves as a genomic enhancer in GR binding regulated <italic>Kappa</italic> expression; indicating a mechanism by which endogenous opioids act on stress systems (<xref rid="B43" ref-type="bibr">Lutz et al., 2017a</xref>).</p><p>Numerous studies have investigated the serotonin transporter gene <italic>SLC6A4</italic>, which facilitates neurotransmitter reuptake at serotonergic synapses. Hypermethylation has been demonstrated at various CpG sites in ELA cohorts depending on sex, ELA magnitude, and type of ELA experienced (ex. physical versus sexual abuse) (<xref rid="B83" ref-type="bibr">Vijayendran et al., 2012</xref>; <xref rid="B1" ref-type="bibr">Alexander et al., 2014</xref>; <xref rid="B3" ref-type="bibr">Booij et al., 2015</xref>; <xref rid="B19" ref-type="bibr">Frodl et al., 2015</xref>). ELA related <italic>SLC6A4</italic> promoter DNA methylation status was also found to be significantly associated with more severe pre-treatment presentation of depressive symptoms, elevated stress, and higher family history of psychopathology (<xref rid="B49" ref-type="bibr">Menke et al., 2012</xref>).</p></sec><sec><title>Growth Factors</title><p>Growth factors, such as brain derived neurotrophic factor (BDNF) and glial cell-derived neurotrophic factor (GDNF), also show differences in expression and DNA methylation related to ELA and MDD. In particular, BDNF has been the subject of significant basic and clinical research with regards to ELA/MDD, as it has been the subject of candidate gene studies, and shows promise as a biomarker and target for epigenome targeted antidepressant therapy.</p><p>In the nucleus accumbens (NAc), glial cell-derived neurotrophic factor (<italic>GDNF)</italic> expression appears to be reduced in chronic early life stressed mice with anxiety- and depressive-like behaviors. This reduction appears to be due to increased DNA methylation related to increased MeCP2 binding (<xref rid="B5" ref-type="bibr">Chahrour et al., 2008</xref>; <xref rid="B80" ref-type="bibr">Uchida et al., 2011</xref>).</p><p>The brain derived neurotrophic factor (<italic>BDNF</italic>) gene is expressed in the adult PFC, and plays a critical role in neural and behavioral plasticity, and the development of psychiatric disorders such as depression, bipolar disorder, and schizophrenia when coupled with ELA (<xref rid="B37" ref-type="bibr">Kundakovic et al., 2014</xref>). Hypomethylation of <italic>BDNF</italic> has been observed in both human PFC tissue in individuals who have experienced ELA, as well as in the PFC of rats exposed to early life stress (<xref rid="B65" ref-type="bibr">Roth et al., 2009</xref>; <xref rid="B66" ref-type="bibr">Roth and Sweatt, 2011</xref>).</p><p>With a significant amount of research substantiating the biological relevance of genes such as <italic>BDNF</italic> in the development of ELA related MDD, reliable estimates of methylation at this locus could potentially be used as a diagnostic tool (<xref rid="T1" ref-type="table">Table 1</xref>) (<xref rid="B20" ref-type="bibr">Fuchikami et al., 2011</xref>; <xref rid="B37" ref-type="bibr">Kundakovic et al., 2014</xref>).</p><p>Taken in context with the established ELA related behavioral vulnerabilities that <italic>BDNF</italic> methylation alterations represent, blood <italic>BDNF</italic> expression and methylation levels could potentially be of clinical use as a tool in clinical care of psychopathologies such as MDD, when coupled with the presentation of symptoms and a reported history of ELA (<xref rid="B70" ref-type="bibr">Shonkoff et al., 2009</xref>).</p><p>One study examined two <italic>BDNF</italic> CpG islands (I and IV) as potential diagnostic biomarkers of MDD. Examining methylation levels at CpG islands I and IV in human cohorts of MDD patients and healthy controls, it was found that CpG 1, but not IV, levels could accurately discriminate controls from the MDD cohort. While this study utilized a relatively small sample size (20 MDD vs. 18 control individuals), it indicated that DNA methylation levels have the potential to be a valuable resource in clinical diagnosis as a biomarker (<xref rid="T1" ref-type="table">Table 1</xref>) (<xref rid="B20" ref-type="bibr">Fuchikami et al., 2011</xref>).</p><p>Clinical research focused on the epigenetic effects of ELA has the potential to not only create new diagnostic procedures, but also to create novel antidepressant therapies that target the epigenome or use the epigenome as a means to evaluate antidepressant efficacy (<xref rid="B62" ref-type="bibr">Qiu et al., 2017</xref>). BDNF in particular appears to be influenced by antidepressant treatment (<xref rid="B21" ref-type="bibr">Fuchikami et al., 2016</xref>). Notably, in several preclinical animal models, treatment with the histone deacetylase (HDAC) inhibitor sodium butyrate has yielded reduced depressive and manic-like behaviors, as well as reversed decreased expression in BDNF and other neurotrophic factors in chronically stressed animal models (<xref rid="B50" ref-type="bibr">Moretti et al., 2011</xref>; <xref rid="B63" ref-type="bibr">Resende et al., 2013</xref>). Similarly, animal models treated with the antidepressant imipramine present with reversed behavioral consequences of early life stress in the <italic>BDNF</italic> promoter region (<xref rid="B77" ref-type="bibr">Tsankova et al., 2006</xref>; <xref rid="B29" ref-type="bibr">Hollis et al., 2010</xref>, <xref rid="B28" ref-type="bibr">2011</xref>; <xref rid="B10" ref-type="bibr">Covington et al., 2011</xref>).</p><p>It has been suggested that effective antidepressant treatment should correspond to an increase in peripheral <italic>BDNF</italic>, and that a sustained lack of increase in <italic>BDNF</italic> over the first week of treatment likely predicts treatment resistance (<xref rid="B75" ref-type="bibr">Tadi&#x00107; et al., 2011</xref>). This finding is based on <italic>BDNF</italic> exon IV promoter methylation data from an MDD cohort being treated with several antidepressants. This effect was mirrored by findings showing that citalopram treatment in MDD patients increased <italic>BDNF</italic> expression in treatment responders, and significantly reduced H3K27me3 levels at the <italic>BDNF</italic> IV promoter (<xref rid="T1" ref-type="table">Table 1</xref>) (<xref rid="B41" ref-type="bibr">Lopez et al., 2013</xref>).</p></sec><sec><title>Animal Models of OTX2</title><p>In an elegant study, <xref rid="B58" ref-type="bibr">Pe&#x000f1;a et al. (2017)</xref> described that juvenile knockdown of the transcription factor orthodenticle homeobox 2 (<italic>Otx2)</italic> in the ventral tegmental area (VTA) &#x02013; a brain reward region- increases stress susceptibility similarly to early life stress. This knockdown of <italic>Otx2</italic> was also associated with downregulation of several target genes, many of which play a role in brain development. Animals in this model also exhibited depressive-like behaviors following a second exposure to stress in adulthood. Based on these findings, the researchers proposed that a &#x0201c;two-hit&#x0201d; stress model may be in effect, wherein ELA increases stress susceptibility in the VTA via <italic>Otx2</italic> mediation, contributing to a depression-like state and sustained transcriptional alterations in adults following adult social defeat. As the association between ELA/MDD and OTX2 has been also reported in humans (<xref rid="B32" ref-type="bibr">Kaufman et al., 2018</xref>), continued investigation into how <italic>Otx2</italic> mediates sustained stress susceptibility is warranted.</p></sec><sec><title>Structural Studies of Myelination</title><p>The role of myelination in ELA/MDD may also be of potential clinical interest. Myelination is essential in developing and maintaining complex cognitive and behavioral functions, as it increases action potential transmission per unit time, thereby increasing the connectivity and information processing capacity of the human brain (<xref rid="B24" ref-type="bibr">Grydeland et al., 2013</xref>). Myelination occurs when oligodendrocytes cells generate myelin, which insulates the neuronal axons and facilitates electrical signal propagation, helping maintain the circuitry of neural networks (such as the axon segments within the cortex), which are crucial to optimizing basic cognitive and behavioral functions (<xref rid="B26" ref-type="bibr">Haroutunian et al., 2014</xref>; <xref rid="B40" ref-type="bibr">Long and Corfas, 2014</xref>). Due to this, reductions in cortical oligodendrocytes and deficits in myelin gene expression have been associated with cognitive and behavioral dysregulations which include- but are not limited to- schizophrenia, bipolar disorder, and MDD (<xref rid="B81" ref-type="bibr">Uranova et al., 2004</xref>). Intracortical myelin abnormalities vary across psychopathologies, with deficits in white matter volume and myelination being more prominent in bipolar disorder and MDD (<xref rid="B52" ref-type="bibr">Mosebach et al., 2013</xref>). With respect to MDD specifically, quantitative magnetic resonance imaging (qMRI) analysis has revealed reduced myelin levels in the white matter of brain regions such as the nucleus accumbens (NAcc) and lateral prefrontal cortex (LPFC) (<xref rid="T1" ref-type="table">Table 1</xref>) (<xref rid="B69" ref-type="bibr">Sacchet and Gotlib, 2017</xref>).</p><p>Structural alterations in white matter have also been associated with ELA in MRI studies, with more recent MRI strategies being able to more effectively investigate white matter myelin content to the level of bundles with hundreds or thousands of axons (<xref rid="B72" ref-type="bibr">Stikov et al., 2015</xref>). Although oligodendrocytes and myelin were long thought to be static, these imaging studies, as well as animal studies, have demonstrated that various forms of learning, as well as social and environmental conditions, correlate with structural changes to white matter. This suggests an important role for myelination in brain plasticity (<xref rid="B40" ref-type="bibr">Long and Corfas, 2014</xref>).</p><p>In the previously summarized recent study by <xref rid="B44" ref-type="bibr">Lutz et al. (2017b)</xref>, state of the art microscopy methods were utilized to more precisely measure microstructural changes to white matter myelin that are associated with ELA. They discovered that in post mortem brain tissue from adults who experienced ELA and died by suicide, axonal integrity and myelination of individual fibers was disrupted, particularly in small-diameter axons which may be related to cortico-cortical projections. These structural alterations were found in conjunction with cell type-specific differences in DNA methylation of oligodendrocyte genes such as <italic>POU3F1</italic> and <italic>LINGO3</italic> in oligodendrocytes (but not neurons), and global decreased expression of a large collection of myelin related genes in the cingulate cortex. These results suggest that ELA may contribute to a neurobiological vulnerability that increases the risk of psychopathology throughout life in affected individuals (<xref rid="T1" ref-type="table">Table 1</xref>) (<xref rid="B44" ref-type="bibr">Lutz et al., 2017b</xref>). These findings may prove of future clinical significance, although further research into the brain region-specific effects of ELA/MDD on myelin is needed before any potential antidepressant therapies or diagnostic procedures related to myelination can be explored further.</p></sec><sec><title>Additional DNA Methylation Studies of Clinical Interest</title><p>BDNF is not the only gene that has potential as a biomarker for MDD in individuals who have experienced ELA. The MORC family CW-type zinc finger 1 (<italic>MORC1)</italic> gene, has been found to be hypermethylated in buccal cells of individuals who experienced ELA and scored high on the Beck Depression Inventory. Researchers have suggested that <italic>MORC1</italic> could reliably be used as a non-invasive diagnostic biomarker for MDD in individuals who have been affected by ELA (<xref rid="T1" ref-type="table">Table 1</xref>) (<xref rid="B53" ref-type="bibr">Mundorf et al., 2018</xref>).</p><p>Other genes implicated in social defeat models of ELA may also serve as promising targets for the future development of novel antidepressant treatments. One mouse model of ELA that presented with altered gene expression in 12 genes in the NAc, including genes coding for actin cytoskeleton reorganization machinery, transcription factors, signaling molecules, and neurotransmitter receptors, that was reversed by treatment with the antidepressant MS-275 (<xref rid="T1" ref-type="table">Table 1</xref>) (<xref rid="B9" ref-type="bibr">Covington et al., 2009</xref>).</p><p>In the prefrontal cortex, DNA methylation of the P11 promoter was reduced in MDD patients via administration of escitalopram, increasing P11 and decreasing the presence of DNA methyltransferases (<xref rid="T1" ref-type="table">Table 1</xref>) (<xref rid="B48" ref-type="bibr">Melas et al., 2012</xref>). The epigenetic changes detailed in these studies represent both potential targets for antidepressant therapy, as well as potential biomarkers of drug efficacy.</p><p>While there has been an ample amount of basic research on the ELA to MDD pipeline examining regions and genes that are differentially methylated in ELA/MDD, clinical research expanding on these findings has been less bountiful. Further clinical studies that examine expression levels of key genes in peripheral tissue (such as buccal swabs or blood) before, during, and after antidepressant treatment in ELA/MDD subjects could feasibly be undertaken to help evaluate the efficacy of many antidepressant treatments, whether they be pharmacological, psychotherapeutic, or through methods such as brain stimulation- the last two of which (to the authors&#x02019; knowledge) &#x02013; remain to be explored.</p></sec><sec><title>Conclusion</title><p>The studies described herein have contributed to our understanding of how ELA can epigenetically regulate behavioral and emotional response systems in the brain in ways that contribute to- and increase the vulnerability to- psychopathologies such as MDD. The research indicates that genes that code for the HPA axis, neurotransmitters, growth factors such as BDNF, transcription factors such as OTX2, and myelination/oligodendrocytes may all play a role in this pathway, demonstrating how diverse and complex the epigenetic alterations associated with ELA likely are. Due to this complexity, it is perhaps not surprising that clinical progress-such as the development of biomarkers for ELA/MD and antidepressant therapies that target the epigenome-has thus far been limited and preliminary. This is why further studies will be necessary before the full potential clinical significance of the basic research into the ELA/MDD pathway can be determined.</p></sec><sec><title>Author Contributions</title><p>AB wrote most of the manuscript, including the entire first draft. LF carried out substantial editing, revisions, and rewrites. GT edited and revised the final draft.</p></sec><sec><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>N.</given-names></name><name><surname>Wankerl</surname><given-names>M.</given-names></name><name><surname>Hennig</surname><given-names>J.</given-names></name><name><surname>Miller</surname><given-names>R.</given-names></name><name><surname>Z&#x000e4;nkert</surname><given-names>S.</given-names></name><name><surname>Steudte-Schmiedgen</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>DNA methylation profiles within the serotonin transporter gene moderate the association of 5-HTTLPR and cortisol stress reactivity.</article-title>
<source><italic>Transl. Psychiatry</italic></source>
<volume>4</volume>:<issue>9</issue>. <pub-id pub-id-type="doi">10.1038/tp.2014.88</pub-id>
<?supplied-pmid 25226552?><pub-id pub-id-type="pmid">25226552</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appel</surname><given-names>K.</given-names></name><name><surname>Schwahn</surname><given-names>C.</given-names></name><name><surname>Mahler</surname><given-names>J.</given-names></name><name><surname>Schulz</surname><given-names>A.</given-names></name><name><surname>Spitzer</surname><given-names>C.</given-names></name><name><surname>Fenske</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Moderation of adult depression by a polymorphism in the FKBP5 gene and childhood physical abuse in the general population.</article-title>
<source><italic>Neuropsychopharmacology</italic></source>
<volume>36</volume>
<fpage>1982</fpage>&#x02013;<lpage>1991</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2011.81</pub-id>
<?supplied-pmid 21654733?><pub-id pub-id-type="pmid">21654733</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Booij</surname><given-names>L.</given-names></name><name><surname>Szyf</surname><given-names>M.</given-names></name><name><surname>Carballedo</surname><given-names>A.</given-names></name><name><surname>Frey</surname><given-names>E.</given-names></name><name><surname>Morris</surname><given-names>D.</given-names></name><name><surname>Dymov</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>DNA methylation of the serotonin transporter gene in peripheral cells and stress-related changes in hippocampal volume: a study in depressed patients and healthy controls.</article-title>
<source><italic>PLoS One</italic></source>
<volume>10</volume>:<issue>3</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0119061</pub-id>
<?supplied-pmid 25781010?><pub-id pub-id-type="pmid">25781010</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cecil</surname><given-names>C. A.</given-names></name><name><surname>Smith</surname><given-names>R. G.</given-names></name><name><surname>Walton</surname><given-names>E.</given-names></name><name><surname>Mill</surname><given-names>J.</given-names></name><name><surname>Mccrory</surname><given-names>E. J.</given-names></name><name><surname>Viding</surname><given-names>E.</given-names></name></person-group> (<year>2016</year>). <article-title>Epigenetic signatures of childhood abuse and neglect: implications for psychiatric vulnerability.</article-title>
<source><italic>J. Psychiatr. Res.</italic></source>
<volume>83</volume>
<fpage>184</fpage>&#x02013;<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychires.2016.09.010</pub-id>
<?supplied-pmid 27643477?><pub-id pub-id-type="pmid">27643477</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chahrour</surname><given-names>M.</given-names></name><name><surname>Jung</surname><given-names>S. Y.</given-names></name><name><surname>Shaw</surname><given-names>C.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Wong</surname><given-names>S. T.</given-names></name><name><surname>Qin</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>MeCP2, a key contributor to neurological disease, activates and represses transcription.</article-title>
<source><italic>Science</italic></source>
<volume>320</volume>
<fpage>1224</fpage>&#x02013;<lpage>1229</lpage>. <pub-id pub-id-type="doi">10.1126/science.1153252</pub-id>
<?supplied-pmid 29405930?><pub-id pub-id-type="pmid">18511691</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname><given-names>D. P.</given-names></name><name><surname>Whitfield</surname><given-names>C. L.</given-names></name><name><surname>Felitti</surname><given-names>V. J.</given-names></name><name><surname>Dube</surname><given-names>S. R.</given-names></name><name><surname>Edwards</surname><given-names>V. J.</given-names></name><name><surname>Anda</surname><given-names>R. F.</given-names></name></person-group> (<year>2004</year>). <article-title>Adverse childhood experiences and the risk of depressive disorders in adulthood.</article-title>
<source><italic>J. Affect. Disord.</italic></source>
<volume>82</volume>
<fpage>217</fpage>&#x02013;<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2003.12.013</pub-id>
<?supplied-pmid 15488250?><pub-id pub-id-type="pmid">15488250</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatzittofis</surname><given-names>A.</given-names></name><name><surname>Arver</surname><given-names>S.</given-names></name><name><surname>&#x000d6;berg</surname><given-names>K.</given-names></name><name><surname>Hallberg</surname><given-names>J.</given-names></name><name><surname>Nordstr&#x000f6;m</surname><given-names>P.</given-names></name><name><surname>Jokinen</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>HPA axis dysregulation in men with hypersexual disorder.</article-title>
<source><italic>Psychoneuroendocrinology</italic></source>
<volume>63</volume>
<fpage>247</fpage>&#x02013;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2015.10.002</pub-id>
<?supplied-pmid 26519779?><pub-id pub-id-type="pmid">26519779</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W. G.</given-names></name><name><surname>Chang</surname><given-names>Q.</given-names></name><name><surname>Lin</surname><given-names>Y.</given-names></name><name><surname>Meissner</surname><given-names>A.</given-names></name><name><surname>West</surname><given-names>A. E.</given-names></name><name><surname>Griffith</surname><given-names>E. C.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Depression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2.</article-title>
<source><italic>Science</italic></source>
<volume>302</volume>
<fpage>885</fpage>&#x02013;<lpage>889</lpage>. <pub-id pub-id-type="doi">10.1126/science.1086446</pub-id>
<?supplied-pmid 14593183?><pub-id pub-id-type="pmid">14593183</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Covington</surname><given-names>H.</given-names></name><name><surname>Maze</surname><given-names>I.</given-names></name><name><surname>LaPlant</surname><given-names>Q.</given-names></name><name><surname>Vialou</surname><given-names>V.</given-names></name><name><surname>Yoshinori</surname><given-names>O.</given-names></name><name><surname>Berton</surname><given-names>O.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Antidepressant actions of HDAC inhibitors.</article-title>
<source><italic>J. Neurosci.</italic></source>
<volume>29</volume>
<fpage>11451</fpage>&#x02013;<lpage>11460</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1758-09.2009</pub-id><pub-id pub-id-type="pmid">19759294</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Covington</surname><given-names>H. E.</given-names></name><name><surname>Vialou</surname><given-names>V. F.</given-names></name><name><surname>Laplant</surname><given-names>Q.</given-names></name><name><surname>Ohnishi</surname><given-names>Y. N.</given-names></name><name><surname>Nestler</surname><given-names>E. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Hippocampal-dependent antidepressant-like activity of histone deacetylase inhibition.</article-title>
<source><italic>Neurosci. Lett.</italic></source>
<volume>493</volume>
<fpage>122</fpage>&#x02013;<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2011.02.022</pub-id>
<?supplied-pmid 21335060?><pub-id pub-id-type="pmid">21335060</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Luca</surname><given-names>V. D.</given-names></name><name><surname>Likhodi</surname><given-names>O.</given-names></name><name><surname>Kennedy</surname><given-names>J. L.</given-names></name><name><surname>Wong</surname><given-names>A. H.</given-names></name></person-group> (<year>2007</year>). <article-title>Differential expression and parent-of-origin effect of the5-HT2A receptor gene C102T polymorphism: analysis of suicidality in schizophrenia and bipolar disorder.</article-title>
<source><italic>Am. J. Med. Genet. Part B</italic></source>
<volume>144B</volume>, <fpage>370</fpage>&#x02013;<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30458</pub-id>
<?supplied-pmid 17221840?><pub-id pub-id-type="pmid">17221840</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Luca</surname><given-names>V. D.</given-names></name><name><surname>Viggiano</surname><given-names>E.</given-names></name><name><surname>Dhoot</surname><given-names>R.</given-names></name><name><surname>Kennedy</surname><given-names>J. L.</given-names></name><name><surname>Wong</surname><given-names>A. H.</given-names></name></person-group> (<year>2009</year>). <article-title>Methylation and QTDT analysis of the 5-HT2A receptor 102C allele: analysis of suicidality in major psychosis.</article-title>
<source><italic>J. Psychiatr. Res.</italic></source>
<volume>43</volume>
<fpage>532</fpage>&#x02013;<lpage>537</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychires.2008.07.007</pub-id>
<?supplied-pmid 18783799?><pub-id pub-id-type="pmid">18783799</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>L.</given-names></name><name><surname>Bakish</surname><given-names>D.</given-names></name><name><surname>Lapierre</surname><given-names>Y. D.</given-names></name><name><surname>Ravindran</surname><given-names>A. V.</given-names></name><name><surname>Hrdina</surname><given-names>P. D.</given-names></name></person-group> (<year>2000</year>). <article-title>Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder.</article-title>
<source><italic>Am. J. Med. Genet.</italic></source>
<volume>96</volume>
<fpage>56</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">10686553</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>L.</given-names></name><name><surname>Faludi</surname><given-names>G.</given-names></name><name><surname>Palkovits</surname><given-names>M.</given-names></name><name><surname>Bakish</surname><given-names>D.</given-names></name><name><surname>Hrdina</surname><given-names>P. D.</given-names></name></person-group> (<year>2001</year>). <article-title>Serotonergic genes and suicidality</article-title>. <source><italic>Crisis</italic></source>
<volume>22</volume>
<fpage>54</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1027//0227-5910.22.2.54</pub-id><pub-id pub-id-type="pmid">11727894</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>V. J.</given-names></name><name><surname>Holden</surname><given-names>G. W.</given-names></name><name><surname>Felitti</surname><given-names>V. J.</given-names></name><name><surname>Anda</surname><given-names>R. F.</given-names></name></person-group> (<year>2003</year>). <article-title>Relationship between multiple forms of childhood maltreatment and adult mental health in community respondents: results from the adverse childhood experiences study.</article-title>
<source><italic>Am. J. Psychiatry</italic></source>
<volume>160</volume>
<fpage>1453</fpage>&#x02013;<lpage>1460</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.160.8.1453</pub-id>
<?supplied-pmid 12900308?><pub-id pub-id-type="pmid">12900308</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>E.</given-names></name><name><surname>Ezra-Nevo</surname><given-names>G.</given-names></name><name><surname>Regev</surname><given-names>L.</given-names></name><name><surname>Neufeld-Cohen</surname><given-names>A.</given-names></name><name><surname>Chen</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Resilience to social stress coincides with functional DNA methylation of the Crf gene in adult mice.</article-title>
<source><italic>Nat. Neurosci.</italic></source>
<volume>13</volume>
<fpage>1351</fpage>&#x02013;<lpage>1353</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2642</pub-id>
<?supplied-pmid 20890295?><pub-id pub-id-type="pmid">20890295</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fergusson</surname><given-names>D.</given-names></name><name><surname>Horwood</surname><given-names>L.</given-names></name><name><surname>Woodward</surname><given-names>L.</given-names></name></person-group> (<year>2000</year>). <article-title>The stability of child abuse reports: a longitudinal study of the reporting behaviour of young adults.</article-title>
<source><italic>Psychol Med.</italic></source>
<volume>30</volume>
<fpage>529</fpage>&#x02013;<lpage>544</lpage>. <pub-id pub-id-type="doi">10.1017/S0033291799002111</pub-id>
<?supplied-pmid 10883709?><pub-id pub-id-type="pmid">10883709</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frodl</surname><given-names>T.</given-names></name><name><surname>Carballedo</surname><given-names>A.</given-names></name><name><surname>Fagan</surname><given-names>A. J.</given-names></name><name><surname>Lisiecka</surname><given-names>D.</given-names></name><name><surname>Ferguson</surname><given-names>Y.</given-names></name><name><surname>Meaney</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Effects of early-life adversity on white matter diffusivity changes in patients at risk for major depression.</article-title>
<source><italic>J. Psychiatry. Neurosci.</italic></source>
<volume>37</volume>
<fpage>37</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1503/jpn.110028</pub-id>
<?supplied-pmid 22008179?><pub-id pub-id-type="pmid">22008179</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frodl</surname><given-names>T.</given-names></name><name><surname>Szyf</surname><given-names>M.</given-names></name><name><surname>Carballedo</surname><given-names>A.</given-names></name><name><surname>Ly</surname><given-names>V.</given-names></name><name><surname>Dymov</surname><given-names>S.</given-names></name><name><surname>Vaisheva</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>DNA methylation of the serotonin transporter gene (SLC6A4) is associated with brain function involved in processing emotional stimuli.</article-title>
<source><italic>J. Psychiatry Neurosci.</italic></source>
<volume>40</volume>
<fpage>296</fpage>&#x02013;<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1503/jpn.140180</pub-id>
<?supplied-pmid 25825812?><pub-id pub-id-type="pmid">25825812</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchikami</surname><given-names>M.</given-names></name><name><surname>Morinobu</surname><given-names>S.</given-names></name><name><surname>Segawa</surname><given-names>M.</given-names></name><name><surname>Okamoto</surname><given-names>Y.</given-names></name><name><surname>Yamawaki</surname><given-names>S.</given-names></name><name><surname>Ozaki</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression.</article-title>
<source><italic>PLoS One</italic></source>
<volume>6</volume>:<issue>8</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0023881</pub-id>
<?supplied-pmid 21912609?><pub-id pub-id-type="pmid">21912609</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchikami</surname><given-names>M.</given-names></name><name><surname>Yamamoto</surname><given-names>S.</given-names></name><name><surname>Morinobu</surname><given-names>S.</given-names></name><name><surname>Okada</surname><given-names>S.</given-names></name><name><surname>Yamawaki</surname><given-names>Y.</given-names></name><name><surname>Yamawaki</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>The potential use of histone deacetylase inhibitors in the treatment of depression.</article-title>
<source><italic>Prog. Neuro Psychopharmacol. Biol. Psychiatry</italic></source>
<volume>64</volume>
<fpage>320</fpage>&#x02013;<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2015.03.010</pub-id>
<?supplied-pmid 25818247?><pub-id pub-id-type="pmid">25818247</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fyffe</surname><given-names>S. L.</given-names></name><name><surname>Neul</surname><given-names>J. L.</given-names></name><name><surname>Samaco</surname><given-names>R. C.</given-names></name><name><surname>Chao</surname><given-names>H.</given-names></name><name><surname>Ben-Shachar</surname><given-names>S.</given-names></name><name><surname>Moretti</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress.</article-title>
<source><italic>Neuron</italic></source>
<volume>59</volume>
<fpage>947</fpage>&#x02013;<lpage>958</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2008.07.030</pub-id>
<?supplied-pmid 18817733?><pub-id pub-id-type="pmid">18817733</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>R.</given-names></name><name><surname>Widom</surname><given-names>C. S.</given-names></name><name><surname>Browne</surname><given-names>K.</given-names></name><name><surname>Fergusson</surname><given-names>D.</given-names></name><name><surname>Webb</surname><given-names>E.</given-names></name><name><surname>Janson</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Burden and consequences of child maltreatment in high-income countries.</article-title>
<source><italic>Lancet</italic></source>
<volume>373</volume>
<fpage>68</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(08)61706-7</pub-id>
<?supplied-pmid 19056114?><pub-id pub-id-type="pmid">19056114</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grydeland</surname><given-names>H.</given-names></name><name><surname>Walhovd</surname><given-names>K.</given-names></name><name><surname>Tamnes</surname><given-names>C.</given-names></name><name><surname>Westlye</surname><given-names>L.</given-names></name><name><surname>Fjell</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Intracortical myelin links with performance variability across the human lifespan: results from T1- and T2-weighted MRI myelin mapping and diffusion tensor imaging.</article-title>
<source><italic>J. Neurosci.</italic></source>
<volume>33</volume>
<fpage>18618</fpage>&#x02013;<lpage>18630</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2811-13.2013</pub-id>
<?supplied-pmid 24259583?><pub-id pub-id-type="pmid">24259583</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guy</surname><given-names>J.</given-names></name><name><surname>Cheval</surname><given-names>H.</given-names></name><name><surname>Selfridge</surname><given-names>J.</given-names></name><name><surname>Bird</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>The role of MeCP2 in the brain.</article-title>
<source><italic>Annu. Rev. Cell Dev. Biol.</italic></source>
<volume>27</volume>
<fpage>631</fpage>&#x02013;<lpage>652</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-cellbio-092910-154121</pub-id>
<?supplied-pmid 21721946?><pub-id pub-id-type="pmid">21721946</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haroutunian</surname><given-names>V.</given-names></name><name><surname>Katsel</surname><given-names>P.</given-names></name><name><surname>Roussos</surname><given-names>P.</given-names></name><name><surname>Davis</surname><given-names>K.</given-names></name><name><surname>Altshuler</surname><given-names>L.</given-names></name><name><surname>Bartzokis</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>Myelination, oligodendrocytes, and serious mental illness.</article-title>
<source><italic>Glia</italic></source>
<volume>62</volume>
<fpage>1856</fpage>&#x02013;<lpage>1877</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22716</pub-id>
<?supplied-pmid 25056210?><pub-id pub-id-type="pmid">25056210</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heim</surname><given-names>C.</given-names></name><name><surname>Binder</surname><given-names>E. B.</given-names></name></person-group> (<year>2012</year>). <article-title>Current research trends in early life stress and depression: review of human studies on sensitive periods, gene&#x02013;environment interactions, and epigenetics.</article-title>
<source><italic>Exp. Neurol.</italic></source>
<volume>233</volume>
<fpage>102</fpage>&#x02013;<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2011.10.032</pub-id>
<?supplied-pmid 22101006?><pub-id pub-id-type="pmid">22101006</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollis</surname><given-names>F.</given-names></name><name><surname>Duclot</surname><given-names>F.</given-names></name><name><surname>Gunjan</surname><given-names>A.</given-names></name><name><surname>Kabbaj</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Individual differences in the effect of social defeat on anhedonia and histone acetylation in the rat hippocampus.</article-title>
<source><italic>Horm. Behav.</italic></source>
<volume>59</volume>
<fpage>331</fpage>&#x02013;<lpage>337</lpage>. <pub-id pub-id-type="doi">10.1016/j.yhbeh.2010.09.005</pub-id>
<?supplied-pmid 20851702?><pub-id pub-id-type="pmid">20851702</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollis</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Dietz</surname><given-names>D.</given-names></name><name><surname>Gunjan</surname><given-names>A.</given-names></name><name><surname>Kabbaj</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>The effects of repeated social defeat on long-term depressive-like behavior and short-term histone modifications in the hippocampus in male Sprague&#x02013;Dawley rats.</article-title>
<source><italic>Psychopharmacology</italic></source>
<volume>211</volume>
<fpage>69</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-010-1869-9</pub-id>
<?supplied-pmid 20454892?><pub-id pub-id-type="pmid">20454892</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Robertson</surname><given-names>K. D.</given-names></name></person-group> (<year>2011</year>). <article-title>DNA methylation: superior or subordinate in the epigenetic hierarchy?</article-title>
<source><italic>Genes Cancer</italic></source>
<volume>2</volume>
<fpage>607</fpage>&#x02013;<lpage>617</lpage>. <pub-id pub-id-type="doi">10.1177/1947601910393957</pub-id>
<?supplied-pmid 21941617?><pub-id pub-id-type="pmid">21941617</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonson-Reid</surname><given-names>M.</given-names></name><name><surname>Kohl</surname><given-names>P.</given-names></name><name><surname>Drake</surname><given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>Child and adult outcomes of chronic child maltreatment.</article-title>
<source><italic>Pediatrics</italic></source>
<volume>129</volume>
<fpage>839</fpage>&#x02013;<lpage>845</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2011-2529</pub-id>
<?supplied-pmid 22529281?><pub-id pub-id-type="pmid">22529281</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufman</surname><given-names>J.</given-names></name><name><surname>Wymbs</surname><given-names>N.</given-names></name><name><surname>Montalvo-Ortiz</surname><given-names>J.</given-names></name><name><surname>Orr</surname><given-names>C.</given-names></name><name><surname>Albaugh</surname><given-names>M.</given-names></name><name><surname>Althoff</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2018</year>). <source><italic>Methylation in OTX2 and Related Genes, Maltreatment, and Depression in Children.</italic></source> Available at: <ext-link ext-link-type="uri" xlink:href="https://www.nature.com/articles/s41386-018-0157-y">https://www.nature.com/articles/s41386-018-0157-y</ext-link> [accessed August 1, 2018].</mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>J.</given-names></name><name><surname>Gomez</surname><given-names>R.</given-names></name><name><surname>Williams</surname><given-names>G.</given-names></name><name><surname>Lembke</surname><given-names>A.</given-names></name><name><surname>Lazzeroni</surname><given-names>L.</given-names></name><name><surname>Murphy</surname><given-names>G. M.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.</article-title>
<source><italic>Mol. Psychiatry</italic></source>
<volume>22</volume>
<fpage>527</fpage>&#x02013;<lpage>536</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2016.120</pub-id>
<?supplied-pmid 27528460?><pub-id pub-id-type="pmid">27528460</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klengel</surname><given-names>T.</given-names></name><name><surname>Mehta</surname><given-names>D.</given-names></name><name><surname>Anacker</surname><given-names>C.</given-names></name><name><surname>Rex-Haffner</surname><given-names>M.</given-names></name><name><surname>Pruessner</surname><given-names>J. C.</given-names></name><name><surname>Pariante</surname><given-names>C. M.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Allele-specific FKBP5 DNA demethylation mediates gene&#x02013;childhood trauma interactions.</article-title>
<source><italic>Nat. Neurosci.</italic></source>
<volume>16</volume>
<fpage>33</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3275</pub-id>
<?supplied-pmid 23201972?><pub-id pub-id-type="pmid">23201972</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>V.</given-names></name><name><surname>Han</surname><given-names>M.</given-names></name><name><surname>Graham</surname><given-names>D.</given-names></name><name><surname>Berton</surname><given-names>O.</given-names></name><name><surname>Renthal</surname><given-names>W.</given-names></name><name><surname>Russo</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions.</article-title>
<source><italic>Cell</italic></source>
<volume>131</volume>
<fpage>391</fpage>&#x02013;<lpage>404</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2007.09.018</pub-id>
<?supplied-pmid 17956738?><pub-id pub-id-type="pmid">17956738</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krugers</surname><given-names>H. J.</given-names></name><name><surname>Arp</surname><given-names>J. M.</given-names></name><name><surname>Xiong</surname><given-names>H.</given-names></name><name><surname>Kanatsou</surname><given-names>S.</given-names></name><name><surname>Lesuis</surname><given-names>S. L.</given-names></name><name><surname>Korosi</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Early life adversity: lasting consequences for emotional learning.</article-title>
<source><italic>Neurobiol. Stress</italic></source>
<volume>6</volume>
<fpage>14</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.ynstr.2016.11.005</pub-id>
<?supplied-pmid 28229105?><pub-id pub-id-type="pmid">28229105</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kundakovic</surname><given-names>M.</given-names></name><name><surname>Gudsnuk</surname><given-names>K.</given-names></name><name><surname>Herbstman</surname><given-names>J. B.</given-names></name><name><surname>Tang</surname><given-names>D.</given-names></name><name><surname>Perera</surname><given-names>F. P.</given-names></name><name><surname>Champagne</surname><given-names>F. A.</given-names></name></person-group> (<year>2014</year>). <article-title>DNA methylation of BDNF as a biomarker of early-life adversity.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>112</volume>
<fpage>6807</fpage>&#x02013;<lpage>6813</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1408355111</pub-id>
<?supplied-pmid 25385582?><pub-id pub-id-type="pmid">25385582</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labont&#x000e9;</surname><given-names>B.</given-names></name><name><surname>Suderman</surname><given-names>M.</given-names></name><name><surname>Maussion</surname><given-names>G.</given-names></name><name><surname>Navaro</surname><given-names>L.</given-names></name><name><surname>Yerko</surname><given-names>V.</given-names></name><name><surname>Mahar</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Genome-wide epigenetic regulation by early-life trauma.</article-title>
<source><italic>Arch. Gen. Psychiatry</italic></source>
<volume>69</volume>:<issue>7</issue>. <pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2011.2287</pub-id>
<?supplied-pmid 22752237?><pub-id pub-id-type="pmid">22752237</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Leeb</surname><given-names>R.</given-names></name><name><surname>Paulozzzi</surname><given-names>L.</given-names></name><name><surname>Melanson</surname><given-names>C.</given-names></name><name><surname>Simon</surname><given-names>T.</given-names></name><name><surname>Arias</surname><given-names>I.</given-names></name></person-group> (<year>2008</year>). <source><italic>Child Maltreatment Surveillance. Uniform Definitions for Public Health and Recommended Data Elements.</italic></source>
<publisher-loc>Atlanta</publisher-loc>: <publisher-name>Centers for Disease Control and Prevention</publisher-name>.</mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>P.</given-names></name><name><surname>Corfas</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>To learn is to myelinate.</article-title>
<source><italic>Science</italic></source>
<volume>346</volume>
<fpage>298</fpage>&#x02013;<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1126/science.1261127</pub-id>
<?supplied-pmid 25324370?><pub-id pub-id-type="pmid">25324370</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>J. P.</given-names></name><name><surname>Mamdani</surname><given-names>F.</given-names></name><name><surname>Labonte</surname><given-names>B.</given-names></name><name><surname>Beaulieu</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>J. P.</given-names></name><name><surname>Berlim</surname><given-names>M. T.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Epigenetic regulation of BDNF expression according to antidepressant response.</article-title>
<source><italic>Mol. Psychiatry</italic></source>
<volume>18</volume>
<fpage>398</fpage>&#x02013;<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2012.38</pub-id>
<?supplied-pmid 22547115?><pub-id pub-id-type="pmid">22547115</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lutz</surname><given-names>P.</given-names></name><name><surname>Almeida</surname><given-names>D.</given-names></name><name><surname>Fiori</surname><given-names>L.</given-names></name><name><surname>Turecki</surname><given-names>G.</given-names></name></person-group> (<year>2015</year>). <article-title>Childhood maltreatment and stress-related psychopathology: the epigenetic memory hypothesis.</article-title>
<source><italic>Curr. Pharm. Des.</italic></source>
<volume>21</volume>
<fpage>1413</fpage>&#x02013;<lpage>1417</lpage>. <pub-id pub-id-type="doi">10.2174/1381612821666150105124928</pub-id>
<?supplied-pmid 25564388?><pub-id pub-id-type="pmid">25564388</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lutz</surname><given-names>P.</given-names></name><name><surname>Gross</surname><given-names>J. A.</given-names></name><name><surname>Dhir</surname><given-names>S. K.</given-names></name><name><surname>Maussion</surname><given-names>G.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Bramoulle</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2017a</year>). <article-title>Epigenetic regulation of the kappa opioid receptor by child abuse.</article-title>
<source><italic>Biol. Psychiatry</italic></source>
<volume>17</volume>
<fpage>31812</fpage>&#x02013;<lpage>31817</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2017.07.012</pub-id>
<?supplied-pmid 28886759?><pub-id pub-id-type="pmid">28886759</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lutz</surname><given-names>P.</given-names></name><name><surname>Tanti</surname><given-names>A.</given-names></name><name><surname>Gasecka</surname><given-names>A.</given-names></name><name><surname>Barnett-Burns</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>J. J.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2017b</year>). <article-title>Association of a history of child abuse with impaired myelination in the anterior cingulate cortex: convergent epigenetic, transcriptional, and morphological evidence.</article-title>
<source><italic>Am. J. Psychiatry</italic></source>
<volume>174</volume>
<fpage>1185</fpage>&#x02013;<lpage>1194</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2017.16111286</pub-id>
<?supplied-pmid 28750583?><pub-id pub-id-type="pmid">28750583</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makinodan</surname><given-names>M.</given-names></name><name><surname>Rosen</surname><given-names>K.</given-names></name><name><surname>Ito</surname><given-names>S.</given-names></name><name><surname>Corfas</surname><given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>A critical period for social experience-dependent oligodendrocyte maturation and myelination.</article-title>
<source><italic>Science</italic></source>
<volume>337</volume>
<fpage>1357</fpage>&#x02013;<lpage>1360</lpage>. <pub-id pub-id-type="doi">10.1126/science.1220845</pub-id>
<?supplied-pmid 22984073?><pub-id pub-id-type="pmid">22984073</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinowich</surname><given-names>K.</given-names></name><name><surname>Hattori</surname><given-names>D.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Fouse</surname><given-names>S.</given-names></name><name><surname>He</surname><given-names>F.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation.</article-title>
<source><italic>Science</italic></source>
<volume>302</volume>
<fpage>890</fpage>&#x02013;<lpage>893</lpage>. <pub-id pub-id-type="doi">10.1126/science.1090842</pub-id>
<?supplied-pmid 14593184?><pub-id pub-id-type="pmid">14593184</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGowan</surname><given-names>P. O.</given-names></name><name><surname>Sasaki</surname><given-names>A.</given-names></name><name><surname>Dalessio</surname><given-names>A. C.</given-names></name><name><surname>Dymov</surname><given-names>S.</given-names></name><name><surname>Labont&#x000e9;</surname><given-names>B.</given-names></name><name><surname>Szyf</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse.</article-title>
<source><italic>Nat. Neurosci.</italic></source>
<volume>12</volume>
<fpage>342</fpage>&#x02013;<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2270</pub-id>
<?supplied-pmid 19234457?><pub-id pub-id-type="pmid">19234457</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melas</surname><given-names>P.</given-names></name><name><surname>Rogdaki</surname><given-names>M.</given-names></name><name><surname>Lennartsson</surname><given-names>A.</given-names></name><name><surname>Bj&#x000f6;rk</surname><given-names>K.</given-names></name><name><surname>Qi</surname><given-names>H.</given-names></name><name><surname>Witasp</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression.</article-title>
<source><italic>Int. J. Neuropsychopharmacol.</italic></source>
<volume>15</volume>
<fpage>669</fpage>&#x02013;<lpage>679</lpage>. <pub-id pub-id-type="doi">10.1017/S1461145711000940</pub-id>
<?supplied-pmid 21682946?><pub-id pub-id-type="pmid">21682946</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menke</surname><given-names>A.</given-names></name><name><surname>Klengel</surname><given-names>T.</given-names></name><name><surname>Binder</surname><given-names>E. B.</given-names></name></person-group> (<year>2012</year>). <article-title>Epigenetics, depression and antidepressant treatment.</article-title>
<source><italic>Curr. Pharm. Des.</italic></source>
<volume>18</volume>
<fpage>5879</fpage>&#x02013;<lpage>5889</lpage>. <pub-id pub-id-type="doi">10.2174/138161212803523590</pub-id><pub-id pub-id-type="pmid">22681167</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moretti</surname><given-names>M.</given-names></name><name><surname>Valvassori</surname><given-names>S. S.</given-names></name><name><surname>Varela</surname><given-names>R. B.</given-names></name><name><surname>Ferreira</surname><given-names>C. L.</given-names></name><name><surname>Rochi</surname><given-names>N.</given-names></name><name><surname>Benedet</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Behavioral and neurochemical effects of sodium butyrate in an animal model of mania.</article-title>
<source><italic>Behav. Pharmacol.</italic></source>
<volume>22</volume>
<fpage>766</fpage>&#x02013;<lpage>772</lpage>. <pub-id pub-id-type="doi">10.1097/fbp.0b013e32834d0f1b</pub-id>
<?supplied-pmid 21989497?><pub-id pub-id-type="pmid">21989497</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>J.</given-names></name><name><surname>Wu Nordahl</surname><given-names>C.</given-names></name><name><surname>Schumann</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). &#x0201c;<article-title>Chapter 3.5 - The amygdala in autism spectrum disorders</article-title>,&#x0201d; in <source><italic>The Neuroscience of Autism Spectrum Disorders</italic></source>, <role>eds</role>
<person-group person-group-type="editor"><name><surname>Buxbaum</surname><given-names>J. D.</given-names></name><name><surname>Hof</surname><given-names>P. R.</given-names></name></person-group> (<publisher-loc>Cambridge, MA</publisher-loc>: <publisher-name>Academic Press</publisher-name>), <fpage>297</fpage>&#x02013;<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-391924-3.00021-1</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosebach</surname><given-names>J.</given-names></name><name><surname>Keilhoff</surname><given-names>G.</given-names></name><name><surname>Gos</surname><given-names>T.</given-names></name><name><surname>Schiltz</surname><given-names>K.</given-names></name><name><surname>Schoeneck</surname><given-names>L.</given-names></name><name><surname>Dobrowolny</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Increased nuclear Olig1-expression in the pregenual anterior cingulate white matter of patients with major depression: a regenerative attempt to compensate oligodendrocyte loss?</article-title>
<source><italic>J. Psychiatric Res.</italic></source>
<volume>47</volume>
<fpage>1069</fpage>&#x02013;<lpage>1079</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychires.2013.03.018</pub-id>
<?supplied-pmid 23615187?><pub-id pub-id-type="pmid">23615187</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mundorf</surname><given-names>A.</given-names></name><name><surname>Schmitz</surname><given-names>J.</given-names></name><name><surname>G&#x000fc;nt&#x000fc;rk&#x000fc;n</surname><given-names>O.</given-names></name><name><surname>Freunda</surname><given-names>N.</given-names></name><name><surname>Ocklenburg</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Methylation of MORC1: a possible biomarker for depression?</article-title>
<source><italic>J. Psychiatric Res.</italic></source>
<volume>103</volume>
<fpage>208</fpage>&#x02013;<lpage>211</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychires.2018.05.026</pub-id>
<?supplied-pmid 29890506?><pub-id pub-id-type="pmid">29890506</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murgatroyd</surname><given-names>C.</given-names></name><name><surname>Patchev</surname><given-names>A. V.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Micale</surname><given-names>V.</given-names></name><name><surname>Bockmuhl</surname><given-names>Y.</given-names></name><name><surname>Fischer</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Dynamic DNA methylation programs persistent adverse effects of early-life stress.</article-title>
<source><italic>Nat. Neurosci.</italic></source>
<volume>12</volume>
<fpage>1559</fpage>&#x02013;<lpage>1566</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2436</pub-id>
<?supplied-pmid 19898468?><pub-id pub-id-type="pmid">19898468</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murri</surname><given-names>M.</given-names></name><name><surname>Prestia</surname><given-names>D.</given-names></name><name><surname>Mondelli</surname><given-names>V.</given-names></name><name><surname>Pariante</surname><given-names>C.</given-names></name><name><surname>Patti</surname><given-names>S.</given-names></name><name><surname>Olivieri</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>The HPA axis in bipolar disorder: systematic review and meta-analysis.</article-title>
<source><italic>Psychoneuroendocrinology</italic></source>
<volume>63</volume>
<fpage>327</fpage>&#x02013;<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2015.10.014</pub-id>
<?supplied-pmid 26547798?><pub-id pub-id-type="pmid">26547798</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nemeroff</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Paradise lost: the neurobiological and clinical consequences of child abuse and neglect.</article-title>
<source><italic>Neuron</italic></source>
<volume>89</volume>
<fpage>892</fpage>&#x02013;<lpage>909</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2016.01.019</pub-id>
<?supplied-pmid 26938439?><pub-id pub-id-type="pmid">26938439</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pariante</surname><given-names>C. M.</given-names></name><name><surname>Lightman</surname><given-names>S. L.</given-names></name></person-group> (<year>2008</year>). <article-title>The HPA axis in major depression: classical theories and new developments.</article-title>
<source><italic>Trends Neurosci.</italic></source>
<volume>31</volume>
<fpage>464</fpage>&#x02013;<lpage>468</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2008.06.006</pub-id>
<?supplied-pmid 18675469?><pub-id pub-id-type="pmid">18675469</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pe&#x000f1;a</surname><given-names>C. J.</given-names></name><name><surname>Kronman</surname><given-names>H. G.</given-names></name><name><surname>Walker</surname><given-names>D. M.</given-names></name><name><surname>Cates</surname><given-names>H. M.</given-names></name><name><surname>Bagot</surname><given-names>R. C.</given-names></name><name><surname>Purushothaman</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Early life stress confers lifelong stress susceptibility in mice via ventral tegmental area OTX2.</article-title>
<source><italic>Science</italic></source>
<volume>356</volume>
<fpage>1185</fpage>&#x02013;<lpage>1188</lpage>. <pub-id pub-id-type="doi">10.1126/science.aan4491</pub-id>
<?supplied-pmid 28619944?><pub-id pub-id-type="pmid">28619944</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perroud</surname><given-names>N.</given-names></name><name><surname>Paoloni-Giacobino</surname><given-names>A.</given-names></name><name><surname>Prada</surname><given-names>P.</given-names></name><name><surname>Oli&#x000e9;</surname><given-names>E.</given-names></name><name><surname>Salzmann</surname><given-names>A.</given-names></name><name><surname>Nicastro</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Increased methylation of glucocorticoid receptor gene (NR3C1) in adults with a history of childhood maltreatment: a link with the severity and type of trauma.</article-title>
<source><italic>Transl. Psychiatry</italic></source>
<volume>1</volume>
<fpage>1</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/tp.2011.60</pub-id>
<?supplied-pmid 22832351?><pub-id pub-id-type="pmid">22832351</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perroud</surname><given-names>N.</given-names></name><name><surname>Salzmann</surname><given-names>A.</given-names></name><name><surname>Prada</surname><given-names>P.</given-names></name><name><surname>Nicastro</surname><given-names>R.</given-names></name><name><surname>Hoeppli</surname><given-names>M.</given-names></name><name><surname>Furrer</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Response to psychotherapy in borderline personality disorder and methylation status of the BDNF gene.</article-title>
<source><italic>Transl. Psychiatry</italic></source>
<volume>3</volume>
<issue>207</issue>. <pub-id pub-id-type="doi">10.1038/tp.2012.140</pub-id>
<?supplied-pmid 23422958?><pub-id pub-id-type="pmid">23422958</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pishva</surname><given-names>E.</given-names></name><name><surname>Rutten</surname><given-names>B.</given-names></name><name><surname>van den Hove</surname><given-names>D.</given-names></name></person-group> (<year>2017</year>). <article-title>DNA methylation in major depressive disorder.</article-title>
<source><italic>Neuroepigenom. Aging Dis.</italic></source>
<volume>978</volume>
<fpage>185</fpage>&#x02013;<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-53889-1_10</pub-id>
<?supplied-pmid 28523547?><pub-id pub-id-type="pmid">28523547</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>X.</given-names></name><name><surname>Xiao</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Histone deacetylases inhibitors (HDACis) as novel therapeutic application in various clinical diseases.</article-title>
<source><italic>Prog. Neuro Psychopharmacol. Biol. Psychiatry</italic></source>
<volume>72</volume>
<fpage>60</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2016.09.002</pub-id>
<?supplied-pmid 27614213?><pub-id pub-id-type="pmid">27614213</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Resende</surname><given-names>W. R.</given-names></name><name><surname>Valvassori</surname><given-names>S. S.</given-names></name><name><surname>R&#x000e9;us</surname><given-names>G. Z.</given-names></name><name><surname>Varela</surname><given-names>R. B.</given-names></name><name><surname>Arent</surname><given-names>C. O.</given-names></name><name><surname>Ribeiro</surname><given-names>K. F.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Effects of sodium butyrate in animal models of mania and depression.</article-title>
<source><italic>Behav. Pharmacol.</italic></source>
<volume>24</volume>
<fpage>569</fpage>&#x02013;<lpage>579</lpage>. <pub-id pub-id-type="doi">10.1097/FBP.0b013e32836546fc</pub-id>
<?supplied-pmid 23994816?><pub-id pub-id-type="pmid">23994816</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohleder</surname><given-names>N.</given-names></name><name><surname>Kirschbaum</surname><given-names>C.</given-names></name></person-group> (<year>2006</year>). <article-title>The hypothalamic&#x02013;pituitary&#x02013;adrenal (HPA) axis in habitual smokers.</article-title>
<source><italic>Int. J. Psychophysiol.</italic></source>
<volume>59</volume>
<fpage>236</fpage>&#x02013;<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpsycho.2005.10.012</pub-id>
<?supplied-pmid 16325948?><pub-id pub-id-type="pmid">16325948</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roth</surname><given-names>T. L.</given-names></name><name><surname>Lubin</surname><given-names>F. D.</given-names></name><name><surname>Funk</surname><given-names>A. J.</given-names></name><name><surname>Sweatt</surname><given-names>J. D.</given-names></name></person-group> (<year>2009</year>). <article-title>Lasting epigenetic influence of early-life adversity on the BDNF gene.</article-title>
<source><italic>Biol. Psychiatry</italic></source>
<volume>65</volume>
<fpage>760</fpage>&#x02013;<lpage>769</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2008.11.028</pub-id>
<?supplied-pmid 19150054?><pub-id pub-id-type="pmid">19150054</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roth</surname><given-names>T. L.</given-names></name><name><surname>Sweatt</surname><given-names>J. D.</given-names></name></person-group> (<year>2011</year>). <article-title>Epigenetic marking of the BDNF gene by early-life adverse experiences.</article-title>
<source><italic>Horm. Behav.</italic></source>
<volume>59</volume>
<fpage>315</fpage>&#x02013;<lpage>320</lpage>. <pub-id pub-id-type="doi">10.1016/j.yhbeh.2010.05.005</pub-id>
<?supplied-pmid 20483357?><pub-id pub-id-type="pmid">20483357</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>A.</given-names></name><name><surname>Gorodetsky</surname><given-names>E.</given-names></name><name><surname>Yuan</surname><given-names>Q.</given-names></name><name><surname>Goldman</surname><given-names>D.</given-names></name><name><surname>Enoch</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide.</article-title>
<source><italic>Neuropsychopharmacology</italic></source>
<volume>35</volume>
<fpage>1674</fpage>&#x02013;<lpage>1683</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2009.236</pub-id>
<?supplied-pmid 20090668?><pub-id pub-id-type="pmid">20090668</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saavedra</surname><given-names>K.</given-names></name><name><surname>Molina-M&#x000e1;rquez</surname><given-names>A.</given-names></name><name><surname>Saavedra</surname><given-names>N.</given-names></name><name><surname>Zambrano</surname><given-names>T.</given-names></name><name><surname>Salazar</surname><given-names>L.</given-names></name></person-group> (<year>2016</year>). <article-title>Epigenetic modifications of major depressive disorder.</article-title>
<source><italic>Int. J. Mol. Sci.</italic></source>
<volume>17</volume>:<issue>1279</issue>. <pub-id pub-id-type="doi">10.3390/ijms17081279</pub-id>
<?supplied-pmid 27527165?><pub-id pub-id-type="pmid">27527165</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sacchet</surname><given-names>M.</given-names></name><name><surname>Gotlib</surname><given-names>H.</given-names></name></person-group> (<year>2017</year>). <article-title>Myelination of the brain in major depressive disorder: an in vivo quantitative magnetic resonance imaging study.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>7</volume>:<issue>1</issue>. <pub-id pub-id-type="doi">10.1038/s41598-017-02062-y</pub-id>
<?supplied-pmid 28526817?><pub-id pub-id-type="pmid">28526817</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shonkoff</surname><given-names>J. P.</given-names></name><name><surname>Boyce</surname><given-names>W. T.</given-names></name><name><surname>Mcewen</surname><given-names>B. S.</given-names></name></person-group> (<year>2009</year>). <article-title>Neuroscience, molecular biology, and the childhood roots of health disparities.</article-title>
<source><italic>JAMA</italic></source>
<volume>301</volume>:<issue>2252</issue>. <pub-id pub-id-type="doi">10.1001/jama.2009.754</pub-id>
<?supplied-pmid 19491187?><pub-id pub-id-type="pmid">19491187</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sterrenburg</surname><given-names>L.</given-names></name><name><surname>Gaszner</surname><given-names>B.</given-names></name><name><surname>Boerrigter</surname><given-names>J.</given-names></name><name><surname>Santbergen</surname><given-names>L.</given-names></name><name><surname>Bramini</surname><given-names>M.</given-names></name><name><surname>Elliott</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Chronic stress induces sex-specific alterations in methylation and expression of corticotropin-releasing factor gene in the rat.</article-title>
<source><italic>PLoS One</italic></source>
<volume>6</volume>:<issue>11</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0028128</pub-id>
<?supplied-pmid 22132228?><pub-id pub-id-type="pmid">22132228</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stikov</surname><given-names>N.</given-names></name><name><surname>Campbell</surname><given-names>J.</given-names></name><name><surname>Stroh</surname><given-names>T.</given-names></name><name><surname>Lavel&#x000e9;e</surname><given-names>M.</given-names></name><name><surname>Frey</surname><given-names>S.</given-names></name><name><surname>Novek</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>In vivo histology of the myelin g-ratio with magnetic resonance imaging.</article-title>
<source><italic>NeuroImage</italic></source>
<volume>118</volume>
<fpage>397</fpage>&#x02013;<lpage>405</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2015.05.023</pub-id>
<?supplied-pmid 26004502?><pub-id pub-id-type="pmid">26004502</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suderman</surname><given-names>M.</given-names></name><name><surname>Borghol</surname><given-names>N.</given-names></name><name><surname>Pappas</surname><given-names>J.</given-names></name><name><surname>Pereira</surname><given-names>S.</given-names></name><name><surname>Pembrey</surname><given-names>M.</given-names></name><name><surname>Hertzman</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Childhood abuse is associated with methylation of multiple loci in adult DNA.</article-title>
<source><italic>Soc. Burden Child Abuse</italic></source>
<volume>7</volume>
<fpage>247</fpage>&#x02013;<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1201/b18768-19</pub-id>
<?supplied-pmid 24618023?><pub-id pub-id-type="pmid">24618023</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suderman</surname><given-names>M.</given-names></name><name><surname>Mcgowan</surname><given-names>P. O.</given-names></name><name><surname>Sasaki</surname><given-names>A.</given-names></name><name><surname>Huang</surname><given-names>T. C.</given-names></name><name><surname>Hallett</surname><given-names>M. T.</given-names></name><name><surname>Meaney</surname><given-names>M. J.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Conserved epigenetic sensitivity to early life experience in the rat and human hippocampus.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>109</volume>
<fpage>17266</fpage>&#x02013;<lpage>17272</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1121260109</pub-id>
<?supplied-pmid 23045659?><pub-id pub-id-type="pmid">23045659</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tadi&#x00107;</surname><given-names>A.</given-names></name><name><surname>Wagner</surname><given-names>S.</given-names></name><name><surname>Schlicht</surname><given-names>K. F.</given-names></name><name><surname>Peetz</surname><given-names>D.</given-names></name><name><surname>Borysenko</surname><given-names>L.</given-names></name><name><surname>Dreim&#x000fc;ller</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot study.</article-title>
<source><italic>Prog. Neuro Psychopharmacol. Biol. Psychiatry</italic></source>
<volume>35</volume>
<fpage>415</fpage>&#x02013;<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2010.08.011</pub-id>
<?supplied-pmid 20732374?><pub-id pub-id-type="pmid">20732374</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>C.</given-names></name><name><surname>Hyponnen</surname><given-names>E.</given-names></name><name><surname>Power</surname><given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>Obesity and type 2 diabetes risk in mid-adult life: the role of childhood adversity.</article-title>
<source><italic>Pediatrics</italic></source>
<volume>121</volume>
<fpage>e1240</fpage>&#x02013;<lpage>e1249</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2007-2403</pub-id>
<?supplied-pmid 18450866?><pub-id pub-id-type="pmid">18450866</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsankova</surname><given-names>N. M.</given-names></name><name><surname>Berton</surname><given-names>O.</given-names></name><name><surname>Renthal</surname><given-names>W.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Neve</surname><given-names>R. L.</given-names></name><name><surname>Nestler</surname><given-names>E. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action.</article-title>
<source><italic>Nat. Neurosci.</italic></source>
<volume>9</volume>
<fpage>519</fpage>&#x02013;<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1038/nn1659</pub-id>
<?supplied-pmid 16501568?><pub-id pub-id-type="pmid">16501568</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turecki</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>The molecular bases of the suicidal brain.</article-title>
<source><italic>Nat. Rev. Neurosci.</italic></source>
<volume>15</volume>
<fpage>802</fpage>&#x02013;<lpage>816</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3839</pub-id>
<?supplied-pmid 25354482?><pub-id pub-id-type="pmid">25354482</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyrka</surname><given-names>A. R.</given-names></name><name><surname>Ridout</surname><given-names>K. K.</given-names></name><name><surname>Parade</surname><given-names>S. H.</given-names></name><name><surname>Paquette</surname><given-names>A.</given-names></name><name><surname>Marsit</surname><given-names>C. J.</given-names></name><name><surname>Seifer</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>Childhood maltreatment and methylation of FK506 binding protein 5 gene (FKBP5).</article-title>
<source><italic>Dev. Psychopathol.</italic></source>
<volume>27</volume>
<fpage>1637</fpage>&#x02013;<lpage>1645</lpage>. <pub-id pub-id-type="doi">10.1017/S0954579415000991</pub-id>
<?supplied-pmid 26535949?><pub-id pub-id-type="pmid">26535949</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uchida</surname><given-names>S.</given-names></name><name><surname>Hara</surname><given-names>K.</given-names></name><name><surname>Kobayashi</surname><given-names>A.</given-names></name><name><surname>Otsuki</surname><given-names>K.</given-names></name><name><surname>Yamagata</surname><given-names>H.</given-names></name><name><surname>Hobara</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events.</article-title>
<source><italic>Neuron</italic></source>
<volume>69</volume>
<fpage>359</fpage>&#x02013;<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.12.023</pub-id>
<?supplied-pmid 21262472?><pub-id pub-id-type="pmid">21262472</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uranova</surname><given-names>N.</given-names></name><name><surname>Vostrikov</surname><given-names>V.</given-names></name><name><surname>Orlovskaya</surname><given-names>D.</given-names></name><name><surname>Rachmanova</surname><given-names>V.</given-names></name></person-group> (<year>2004</year>). <article-title>Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the stanley neuropathology consortium.</article-title>
<source><italic>Schizophr. Res.</italic></source>
<volume>67</volume>
<fpage>269</fpage>&#x02013;<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1016/S0920-9964(03)00181-6</pub-id>
<?supplied-pmid 14984887?><pub-id pub-id-type="pmid">14984887</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="book"><collab>US Department of Health, and Human Services</collab> (<year>2008</year>). <source><italic>Administration on Children youth, and Families. Child Maltreatment 2006.</italic></source>
<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>US Government Printing Office</publisher-name>.</mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijayendran</surname><given-names>M.</given-names></name><name><surname>Cutrona</surname><given-names>C.</given-names></name><name><surname>Beach</surname><given-names>S. R.</given-names></name><name><surname>Brody</surname><given-names>G. H.</given-names></name><name><surname>Russell</surname><given-names>D.</given-names></name><name><surname>Philibert</surname><given-names>R. A.</given-names></name></person-group> (<year>2012</year>). <article-title>The relationship of the serotonin transporter (SLC6A4) extra long variant to gene expression in an African American sample.</article-title>
<source><italic>Am. J. Med. Genet. Part B</italic></source>
<volume>159B</volume>, <fpage>611</fpage>&#x02013;<lpage>612</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.32054</pub-id>
<?supplied-pmid 22553133?><pub-id pub-id-type="pmid">22553133</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>I. C.</given-names></name><name><surname>D&#x02019;Alessio</surname><given-names>A. C.</given-names></name><name><surname>Brown</surname><given-names>S. E.</given-names></name><name><surname>Hellstrom</surname><given-names>I. C.</given-names></name><name><surname>Dymov</surname><given-names>S.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>The transcription factor nerve growth factor-inducible protein a mediates epigenetic programming: altering epigenetic marks by immediate-early genes.</article-title>
<source><italic>J. Neurosci.</italic></source>
<volume>27</volume>
<fpage>1756</fpage>&#x02013;<lpage>1768</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4164-06.2007</pub-id>
<?supplied-pmid 17301183?><pub-id pub-id-type="pmid">17301183</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>I. C.</given-names></name><name><surname>Hellstrom</surname><given-names>I. C.</given-names></name><name><surname>Brown</surname><given-names>S. E.</given-names></name><name><surname>Andrews</surname><given-names>S. D.</given-names></name><name><surname>Dymov</surname><given-names>S.</given-names></name><name><surname>Diorio</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>The methylated-DNA binding protein MBD2 enhances NGFI-A (egr-1)-mediated transcriptional activation of the glucocorticoid receptor.</article-title>
<source><italic>Philos. Trans. R. Soc. Lond. B Biol. Sci.</italic></source>
<volume>369</volume>
<issue>20130513</issue>. <pub-id pub-id-type="doi">10.1098/rstb.2013.0513</pub-id>
<?supplied-pmid 25135974?><pub-id pub-id-type="pmid">25135974</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weder</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Jensen</surname><given-names>K.</given-names></name><name><surname>Yang</surname><given-names>B. Z.</given-names></name><name><surname>Simen</surname><given-names>A.</given-names></name><name><surname>Jackowski</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Child abuse, depression, and methylation in genes involved with stress, neural plasticity, and brain circuitry.</article-title>
<source><italic>J. Am. Acad. Child Adolesc. Psychiatry</italic></source>
<volume>53</volume>:<issue>4</issue>. <pub-id pub-id-type="doi">10.1016/j.jaac.2013.12.025</pub-id>
<?supplied-pmid 24655651?><pub-id pub-id-type="pmid">24655651</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Withers</surname><given-names>A. C.</given-names></name><name><surname>Tarasoff</surname><given-names>J. M.</given-names></name><name><surname>Stewart</surname><given-names>J. W.</given-names></name></person-group> (<year>2013</year>). <article-title>Is depression with atypical features associated with trauma history?</article-title>
<source><italic>J. Clin. Psychiatry.</italic></source>
<volume>74</volume>
<fpage>500</fpage>&#x02013;<lpage>506</lpage>. <pub-id pub-id-type="doi">10.4088/JCP.12m07870</pub-id>
<?supplied-pmid 23759453?><pub-id pub-id-type="pmid">23759453</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodman</surname><given-names>J.</given-names></name><name><surname>Pitt</surname><given-names>M.</given-names></name><name><surname>Wentz</surname><given-names>R.</given-names></name><name><surname>Taylor</surname><given-names>B.</given-names></name><name><surname>Hodes</surname><given-names>D.</given-names></name><name><surname>Gilbert</surname><given-names>R.</given-names></name></person-group> (<year>2008</year>). <article-title>Performance of screening tests for child physical abuse in accident and emergency departments.</article-title>
<source><italic>Health Technol. Assess.</italic></source>
<volume>12</volume>:<issue>118</issue>. <pub-id pub-id-type="doi">10.3310/hta12330</pub-id>
<?supplied-pmid 18992184?><pub-id pub-id-type="pmid">18992184</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="book"><collab>World Health Organization [WHO]</collab> (<year>2017</year>). <source><italic>Depression and Other Common Mental: Disorders Global Health Estimates.</italic></source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>.</mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zajecka</surname><given-names>J.</given-names></name><name><surname>Kornstein</surname><given-names>S. G.</given-names></name><name><surname>Blier</surname><given-names>P.</given-names></name></person-group> (<year>2013</year>). <article-title>Residual symptoms in major depressive disorder: prevalence, effects, and management.</article-title>
<source><italic>J. Clin. Psychiatry</italic></source>
<volume>74</volume>
<fpage>407</fpage>&#x02013;<lpage>414</lpage>. <pub-id pub-id-type="doi">10.4088/jcp.12059ah1</pub-id>
<?supplied-pmid 23656849?><pub-id pub-id-type="pmid">23656849</pub-id></mixed-citation></ref></ref-list></back></article>